View Author
patient chemotherapy memory b cells memory quantitation tumor group dilution b cells probe myeloma treatment number leukemia blood tumor cells value asopcr center compartment lymphoblastic leukemia study consensus mr group variation mr vs sample marrow product dilution assay sequence table subset plasmablast b cells coefficient assay / iga lymphoblastic van tilburg cm childhood cessation reference variation coefficient multicenter 104 weeks myeloma tumor cells lymphocyte compartment composition pcr product level vh 3fr probe 27− article lymphocyte 1 year primers figure pcr intra pcr strategy b cell compartment cd 27+ igg tilburg 27+ igh asopcr consensus strategy intra amount therapy patient h van tilburg b cell numbers plasmablast reference values cycle 21− press amplification 38− myeloma patients result asopcr product
2 Most Recent Publications
|
Reduced versus intensive chemotherapy for childhood acute lymphoblastic leukemia: Impact on lymphocyte compartment composition
(Article)
Tilburg, C.M. van Velden, V.H.J. van der Sanders, E.A. Wolfs, T.F.W. Gaiser, J.F. Haas, V. de Pieters, R. Bloem, A. Bierings, M. |
2010-01-01
|
|
Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study. Belgium-Dutch Hematology-Oncology Group
(Article)
Willems, P. Veenhuizen, P. Bloem, A. Vellenga, E. Schoot, E. van der Bos, N. Verhagen, O. Segeren, C. Wiemer, E.A.C. Lokhorst, H. Guikema, J. Groothuis, L. Sonneveld, P. Raymakers, R. Jong, T.B. Kok, H. Mensink, E. |
2000-01-01
|